Molecular Insight Pharmaceuticals of Cambridge, MA, has posted financial results for its first quarter of 2008.
For the period (end-March 31), the company's total revenues were $88,265, compared with $247,567 in 2007, a decrease of 64%. Revenues consisted of grants from the National Institutes of Health, according to Molecular Insight.
Net loss for the first quarter was $19.7 million, compared with a net loss of $14.8 million for the same period in 2007.
Related Reading
Molecular Insight launches new Azedra trials, May 1, 2008
Molecular Insight raises $150 million, November 12, 2007
Molecular Insight completes phase I Azedra trial, October 18, 2007
Molecular Insight buys manufacturing site, October 3, 2007
Molecular Insight appoints CFO, August 16, 2007
Copyright © 2008 AuntMinnie.com
